First AD

Second AD

CURE Connections 

Metastatic Triple Negative Breast Cancer: Overcoming Challenges in Diagnosis Treatment and Management

Receiving a cancer diagnosis is life-altering. Although every situation is unique, the emotional experience and need for guidance and support is universal. You will undoubtedly have many questions and concerns. At CURE, we recognize the power of information and community. Our medical experts, patient guests, caregivers, and family members featured on CURE Connections® are here to share their insights based on their own knowledge and experiences.

Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.

Second-Line Therapy for Metastatic TNBC

Background on Metastatic Triple Negative Breast Cancer

Initial Treatment Options for Metastatic TNBC

ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC

Managing Adverse Events in Patients Receiving Later Line Systemic Therapy for Metastatic TNBC

Overcoming Barriers to Treatment Access and Reimbursement

Second-Line Therapy for Metastatic TNBC

Latest News